Biotechnology News

September 9, 2014

NEW HAVEN, Conn.--(BUSINESS WIRE)--Kolltan Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs), today announced the...

September 9, 2014

ROCHESTER, N.Y.--(BUSINESS WIRE)--ACM Global Central Laboratory Officially Opens New Shanghai Lab Facility. Newest Lab Facility Leverages Local Expertise to Extend ACM Global’s Robust Capabilities across China and Surrounding Regions.

September 9, 2014

SAN DIEGO--(BUSINESS WIRE)--Ansun BioPharma announced today a late breaker oral presentation titled “DAS181 for the Treatment of Parainfluenza Virus Infections in 16 Hematopoietic Stem Cell Transplant Recipients” by Dr. Mirella Salvatore of Weill...

September 9, 2014

ROCHESTER, N.Y.--(BUSINESS WIRE)--Cincinnati Children’s Hospital Medical Center (Cincinnati, Ohio) recently installed a CARESTREAM DRX-Revolution Mobile X-ray System.

September 9, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--FORM 8.1(a)&(b)(i) IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.1(a) AND (b)(i) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY OFFERORS, OFFEREES OR PARTIES ACTING IN CONCERT WITH...

September 9, 2014

EVRY, France--(BUSINESS WIRE)--Regulatory News : Global Bioenergies (Paris:ALGBE) announces the appointment of François-Henri Sahakian as Chief Financial Officer. François-Henri Sahakian started his career as a business analyst at Oseo (now...

September 9, 2014

HALIFAX, Nova Scotia--(BUSINESS WIRE)--The semi-finalists have been chosen for the 2014 edition of The BioInnovation Challenge (BIC). Scott Moffitt, Managing Director of BioNova, the host of BIC, announced today that a selection committee has...

September 9, 2014

NEWARK, N.J.--(BUSINESS WIRE)--Symbiomix Therapeutics, a late-stage, privately held, biopharmaceutical company with a focus on women’s health, today made its first corporate announcement. The company reported completion of enrollment in a Phase 2...

September 9, 2014

WASHINGTON--(BUSINESS WIRE)--The year's hottest IP business deals have received LES (USA & Canada) Deals of Distinction Awards. Winners including Google and Lenovo will accept their awards at the LES Annual Meeting Oct 5-8 in CA.

September 9, 2014

GOLDEN, Colo.--(BUSINESS WIRE)--Mountain Blue Cancer Care Center in Golden, Colorado, is changing how advanced cancer is treated with genomic tumor profiling and a “lowest effective dose” approach to chemotherapy.

September 9, 2014

HUDSON, Mass.--(BUSINESS WIRE)--Boyd Coatings Research Co., Inc. now offers fully-validated, biocompatible, FDA-compliant PVDF coatings in fifteen colors. PVDF is a popular choice for coating and legibly marking medical devices.

September 9, 2014

LOS ANGELES--(BUSINESS WIRE)--Contact Glancy Binkow & Goldberg LLP if you purchased ordinary shares of Prosensa Holding N.V. in connection with the Company’s June 28, 2013, initial public offering.

September 9, 2014

GENEVA & BOSTON--(BUSINESS WIRE)--Medimaps Group announced today that a novel method for improving osteoporotic fracture risk assessment, TBS iNsight®, is now globally available to clinicians through a distribution partnership with General...

September 9, 2014

BOSTON--(BUSINESS WIRE)--Halloran Consulting Group, Inc. (Halloran) today announced the recent hiring of Greg Shipp, MD, formerly with Regenesis Biomedical where he served as Director of Clinical Research; Laura Giannini, RPh, MBA, previously...

September 9, 2014

NORTHBROOK, Ill.--(BUSINESS WIRE)--Marathon Pharmaceuticals, LLC today announced the availability of ZiNGO® powder intradermal injection system, a needle-free, easy to use device to manage venous access pain.

September 9, 2014

BOULDER, Colo.--(BUSINESS WIRE)--Biodesix VeriStrat diagnostic deemed medically necessary to guide treatment decisions in lung cancer.

September 9, 2014

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, Ph.D. will present at...

September 9, 2014

BALTIMORE--(BUSINESS WIRE)--As the Ebola epidemic grows in Africa, scientists of the Global Virus Network (GVN) are leading the world in their efforts to develop therapeutic drug therapy and effective vaccine candidates to treat and prevent the...

September 9, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dr. Sangeeta Bhatia, biomedical engineer and professor at MIT, is the recipient of the 2014 $500,000 Lemelson-MIT Prize.

September 9, 2014

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced it has expanded its global license agreement with CURx Pharmaceuticals, Inc. to also include the development and commercialization of Ligand’s Captisol-...

September 9, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq:XNPT) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) announced today that they have entered into an agreement to conduct a clinical trial of HORIZANT® (gabapentin...

September 9, 2014

YOKOHAMA, Japan--(BUSINESS WIRE)--ReproCELL Acquires the iPS Cell Business Unit of Stemgent, Inc.

September 9, 2014

NEW HAVEN, Conn.--(BUSINESS WIRE)--Trevi Therapeutics Selected to Exhibit Poster at 2014 Annual Meeting of the American College of Clinical Pharmacology

September 9, 2014

ST. LOUIS--(BUSINESS WIRE)--Euclises Pharmaceuticals, Inc., a biotechnology company developing novel COX-2 inhibitors for the treatment of cancer, today announced closing a $1.3 million Series A financing.

September 9, 2014

PERKASIE, Pa.--(BUSINESS WIRE)--Peter Gabriele and Jeremy Harris, Ph.D., will present “Anatomy of a Next-Generation Bioresorbable Coating for Medical Devices” during a live webinar Tuesday, September 23 at 11:00 am (ET).

September 9, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mersana Therapeutics has announced the USPTO granted patents that strengthen protections for Mersana's internal pipeline of Fleximer antibody-drug conjugates, as well as partnered programs.

September 9, 2014

MEQUON, Wis.--(BUSINESS WIRE)--ENDECE will present new, pre-clinical data for its lead compound, NDC-1308, inducing remyelination in vivo in animal model of demyelination at a poster session at the 2014 ACTRIMS/ECTRIMS meeting.

September 9, 2014

WOBURN, Mass.--(BUSINESS WIRE)--Aphios awarded SBIR grant from NCCAM, NIH to design and develop instrumentation for its green drug discovery technology that improves the discovery rate of natural therapeutics and QOL medicines.

September 9, 2014

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (NASDAQ: CLVS) announced today that the initial purchasers of the previously announced offering of the Company’s 2.50% Convertible Senior Notes due 2021 (the “Notes”) in a private placement...

September 9, 2014

OSLO, Norway--(BUSINESS WIRE)--Serodus has succesfully completed a Phase IIa clinical trial for its lead candidate drug SER100 in patients with systolic hypertension

September 9, 2014

DALLAS & FORT WORTH, Texas--(BUSINESS WIRE)--Neos Therapeutics, Inc. (“Neos”), a specialty pharmaceutical company with a portfolio of novel and proprietary oral drug delivery technologies as well as a late-stage pipeline of innovative...

September 9, 2014

--(BUSINESS WIRE)--CKR Global, Canada’s leading risk mitigation company, combats 5 myths about Canadian companies' vulnerability to RCMP scrutiny and enforcement of the Corruption of Foreign Public Officials Act.

September 9, 2014

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides CEO Dr. Seymour to present the Company's programs with particular reference to the current Ebola outbreak at the Rodman & Renshaw Conference in New York City today afternoon.

September 9, 2014

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals Makes Decision to Advance SPI-2012, a Novel Long-Acting GCSF, to a Phase 3 Due to Positive Phase 2 Results in its Collaboration Program with Hanmi Pharm. Co.

September 9, 2014

NEW YORK--(BUSINESS WIRE)--Deerfield Management Company announced today it has committed to invest $125 million in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) through senior secured convertible notes. The financing is expected to be funded before...

September 9, 2014

SAN DIEGO--(BUSINESS WIRE)--OncoSec Medical to Present Data at ESMO 2014 Congress

September 9, 2014

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced the initiation of enrollment in an open-label Phase 1b clinical trial designed to...

September 9, 2014

BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C. & NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of...

September 9, 2014

LEIDEN, Netherlands--(BUSINESS WIRE)--Anders Harfstrand Joins to-BBB as Chief Executive Officer

September 9, 2014

INGELHEIM, Germany--(BUSINESS WIRE)--For media outside UK, US and Canada A pre-specified subgroup analysis from the two replicate Phase III INPULSIS™ trials, presented today at the European Respiratory Society International Congress (ERS), showed...

September 9, 2014

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: NeuroVive Pharmaceutial AB (STO:NVP), a leading mitochondrial medicine company, has signed an exclusive global outlicensing agreement with the US biotechnology company OnCore BioPharma, Inc. related to...

September 9, 2014

SEATTLE--(BUSINESS WIRE)--Acucela Inc. (TOKYO:4589), a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, today...

September 8, 2014

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) announced today it will present at the 21st Annual BioCentury NewsMakers Conference on Friday, September 26, 2014 at 2:00 p.m. (EDT) in New York. The presentation will be webcast...

September 8, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ: EXEL) today announced that Michael M. Morrissey, Ph.D., the company’s president and chief executive officer, will provide an overview of the company at the Morgan Stanley...

September 8, 2014

BOSTON--(BUSINESS WIRE)--Flex Pharma, Inc., a biopharmaceutical company dedicated to creating innovative, novel treatments for neuromuscular disorders, announced today that it has raised $40 million in private funding from a number of blue chip...

September 8, 2014

CARLSBAD, Calif. & BOSTON--(BUSINESS WIRE)--The seventh annual BioPharm America™ international life science partnering conference will kick off in a less than two weeks, September 22–24, at Boston Marriott Copley Place.

September 8, 2014

ATLANTA--(BUSINESS WIRE)--September is peripheral artery disease awareness month. PAD costs more than other major chronic diseases. Costs reflect PAD events plus cardiovascular events, diabetic foot ulcers and amputations.

September 8, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has signed a contract with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to...